Search
Related
Outcome of fibrillary glomerulonephritis.
Kalbermatter S, Marone C, Casartelli D, Hausberg M, Banfi G, Mihatsch M, Dickenmann M.
Swiss Med Wkly. 2012 May 2;142:0. doi: 10.4414/smw.2012.13578
22553112
[PubMed - in process] Free Article nohighlight
Related citations
Bisphenol A Induces Gene Expression Changes and Proliferative Effects through GPER in Breast Cancer Cells and Cancer-Associated Fibroblasts.
Pupo M, Pisano A, Lappano R, Santolla MF, De Francesco EM, Abonante S, Rosano C, Maggiolini M.
Environ Health Perspect. 2012 May 2. [Epub ahead of print
22552965
[PubMed - as supplied by publisher] Free Article nohighlight
Related citations
Reduced renal plasma clearance does not explain increased plasma asymmetric dimethylarginine in hypertensive subjects with mild to moderate renal insufficiency.
Ronden RA, Houben AJ, Teerlink T, Bakker JA, Bierau J, Stehouwer CD, de Leeuw PW, Kroon AA.
Am J Physiol Renal Physiol. 2012 May 2. [Epub ahead of print
22552932
[PubMed - as supplied by publisher] nohighlight
Related citations
Targeted Therapy for Gastric Cancer.
Smyth EC, Cunningham D.
Curr Treat Options Oncol. 2012 May 3. [Epub ahead of print
22552927
[PubMed - as supplied by publisher] nohighlight
Related citations
Phthalates stimulate the epithelial to mesenchymal transition through an HDAC6-dependent mechanism in human breast epithelial stem cells.
Hsieh TH, Tsai CF, Hsu CY, Kuo PL, Lee JN, Chai CY, Hou MF, Chang CC, Ko YC, Tsai EM.
Toxicol Sci. 2012 May 2. [Epub ahead of print
22552774
[PubMed - as supplied by publisher] nohighlight
Related citations
CD44 enhances the epithelial-mesenchymal transition in association with colon cancer invasion.
Cho SH, Park YS, Kim HJ, Kim CH, Lim SW, Huh JW, Lee JH, Kim HR.
Int J Oncol. 2012 Jul;41(1):211-8. doi: 10.3892/ijo.2012.1453. Epub 2012 Apr 30
22552741
[PubMed - in process] nohighlight
Related citations
[Critically appraised article].
Neumann I, Grassi B.
Rev Med Chil. 2012 Jan;140(1):117-20. Epub 2012 Apr 12. Spanish.
22552566
[PubMed - in process] Free Article nohighlight
Related citations
Simultaneous targeting of EGFR and mTOR inhibits the growth of colorectal carcinoma cells.
Li B, Gao S, Wei F, Bellail AC, Hao C, Liu T.
Oncol Rep. 2012 Jul;28(1):15-20. doi: 10.3892/or.2012.1786. Epub 2012 Apr 26
22552366
[PubMed - in process] nohighlight
Related citations
Characterization of EGFR and ErbB2 expression in atopic dermatitis patients.
Sääf A, Pivarcsi A, Winge MC, Wahlgren CF, Homey B, Nordenskjöld M, Tengvall-Linder M, Bradley M.
Arch Dermatol Res. 2012 May 3. [Epub ahead of print
22552355
[PubMed - as supplied by publisher] nohighlight
Related citations
Combined EGFR/MET or EGFR/HSP90 inhibition is effective in the treatment of lung cancers co-driven by mutant EGFR containing T790M and MET.
Xu L, Kikuchi E, Xu C, Ebi H, Ercan D, Cheng KA, Padera RF Jr, Engelman JA, Janne PA, Shapiro GI, Shimamura T, Wong KK.
Cancer Res. 2012 May 2. [Epub ahead of print
22552292
[PubMed - as supplied by publisher] nohighlight
Related citations
Oncogenic PI3K mutations lead to NF-κB-dependent cytokine expression following growth factor deprivation.
Hutti JE, Pfefferle AD, Russell SC, Sircar M, Perou CM, Baldwin AS.
Cancer Res. 2012 May 2. [Epub ahead of print
22552288
[PubMed - as supplied by publisher] nohighlight
Related citations
MEK inhibition leads to PI3K/AKT activation by relieving a negative feedback on ERBB receptors.
Turke AB, Song Y, Costa C, Cook R, Arteaga CL, Asara JM, Engelman JA.
Cancer Res. 2012 May 2. [Epub ahead of print
22552284
[PubMed - as supplied by publisher] nohighlight
Related citations
Integrated effect of EGFR and PAR-1 signaling crosstalk on airway hyperresponsiveness.
Yoshikawa T, Kanazawa H.
Int J Mol Med. 2012 Jul;30(1):41-8. doi: 10.3892/ijmm.2012.981. Epub 2012 Apr 23
22552271
[PubMed - in process] nohighlight
Related citations
Directed Therapies in Lung Cancer: New Hope?
Parente Lamelas I, Abal Arca J, Fírvida Pérez JL.
Arch Bronconeumol. 2012 Apr 30. [Epub ahead of print] English, Spanish.
22551924
[PubMed - as supplied by publisher] Free Article nohighlight
Related citations
The effect of combined calcium and cholecalciferol supplementation on bone mineral density in elderly women with moderate chronic kidney disease.
Bosworth C, de Boer IH, Targher G, Kendrick J, Smits G, Chonchol M.
Clin Nephrol. 2012 May;77(5):358-65
22551881
[PubMed - in process] nohighlight
Related citations
Renal Toxicity of Long-Term Therapy With Tenofovir in HIV-Infected Patients.
Monteagudo-Chu MO, Chang MH, Fung HB, Bräu N.
J Pharm Pract. 2012 May 2. [Epub ahead of print
22551561
[PubMed - as supplied by publisher] nohighlight
Related citations
Triple Negative Breast Cancer: A Brief Review of its Characteristics and Treatment Options.
Griffths CL, Olin JL.
J Pharm Pract. 2012 May 2. [Epub ahead of print
22551559
[PubMed - as supplied by publisher] nohighlight
Related citations
Guidelines for biomarker testing in advanced non-small-cell lung cancer. A National Consensus of the Spanish Society of Medical Oncology (SEOM) and the Spanish Society of Pathology (SEAP).
Garrido P, de Castro J, Concha A, Felip E, Isla D, López-Ríos F, Paz-Ares L, Ramírez J, Sanz J, Gómez JJ.
Clin Transl Oncol. 2012 May;14(5):338-49
22551539
[PubMed - in process] nohighlight
Related citations
Distinct soluble EGFR isoforms expressed in non-small-cell lung cancer cells compared with normal tissue.
Neagu M, Albulescu R, Tanase C.
Biomark Med. 2012 Apr;6(2):198-9. doi: 10.2217/BMM.12.5. No abstract available.
22550753
[PubMed - in process] nohighlight
Related citations
The Evolving Role of Maintenance Therapy Using Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors (EGFR TKIs) in the Management of Advanced Non-Small-Cell Lung Cancer.
Huang CH, Powers BC.
Clin Med Insights Oncol. 2012;6:137-47. Epub 2012 Mar 12
22550402
[PubMed - in process] Free PMC Article nohighlight
Related citations